Company attributes
B2X
Founder
Pitchbook URL
Legal Name
PhagoMed Biopharma GmbH
Parent Organization
Date Incorporated
2017
Number of Employees (Ranges)
11 – 50
Number of Employees
14
Full Address
Leberstraße 20 1110 Vienna Austria
Founded Date
November 23, 2017
Email Address
contact@phagomed.com
Total Funding Amount (USD)
6,400,000
Latest Funding Type
Country
Other attributes
Company Operating Status
Active
PhagoMed Biopharma is a biotechnology company developing phage therapies to replace ineffective antibiotics that is headquartered in Vienna, Austria and was founded in 2017 by Alexander Belcredi and Burkhard Wippermann.
Products
PM398
PM398 is a phage therapy designed to destroy multi-drug resistant methicillin-resistant Staphylococcus aureus (MRSA).
Funding
Seed
On August 28, 2018 PhagoMed Biopharma completed a seed funding round with €4M in funding from from undisclosed investors.
Timeline
No Timeline data yet.